PriceTracker GLP-1

GLP-1 TV · News & media · views checked Oct 2026

Retatrutide Before FDA Approval? Lilly Just Changed the Conversation

News & mediaOn The Pen™ GLP-1 News15,129 views20:32Jun 2026

Our summary

A news or media piece explains how Zepbound works and what the evidence says, mentioning 15 mg. Side effects mentioned: fatigue. Also covers injection technique, cost and insurance and the trials.

General education as published by the channel. Not medical advice, and not an endorsement.

Key moments

Where the talk turns, found in the captions. Tap one to play from there.

  1. 1:23 Injection technique
  2. 5:14 The trials
  3. 13:54 Cost and insurance
  4. 17:58 Wrapping up

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Zepbound and retatrutide
Doses mentioned
15 mg
Side effects mentioned
fatigue
Who is speaking
News or media

Find more like it

Dose changeInjection techniqueCost and insuranceThe trialsFatigue

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV